Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Other Accumulated Expenses (2018 - 2023)

Avai Bio's Other Accumulated Expenses history spans 4 years, with the latest figure at $244218.0 for Q1 2023.

  • For Q1 2023, Other Accumulated Expenses changed N/A year-over-year to $244218.0; the TTM value through Mar 2023 reached $244218.0, changed N/A, while the annual FY2023 figure was $244218.0, N/A changed from the prior year.
  • Other Accumulated Expenses for Q1 2023 was $244218.0 at Avai Bio, down from $968356.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $968356.0 in Q4 2020 and bottomed at $80135.0 in Q1 2019.
  • The 3-year median for Other Accumulated Expenses is $350937.5 (2020), against an average of $392102.9.
  • The largest annual shift saw Other Accumulated Expenses surged 1203.33% in 2019 before it surged 173.57% in 2020.
  • A 3-year view of Other Accumulated Expenses shows it stood at $221745.0 in 2019, then surged by 336.7% to $968356.0 in 2020, then tumbled by 74.78% to $244218.0 in 2023.
  • Per Business Quant, the three most recent readings for AVAI's Other Accumulated Expenses are $244218.0 (Q1 2023), $968356.0 (Q4 2020), and $606625.0 (Q3 2020).